R Maggio
Overview
Explore the profile of R Maggio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
801
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rizzo V, Mastroeni C, Maggio R, Terranova C, Girlanda P, Siebner H, et al.
Clin Neurophysiol
. 2020 Aug;
131(10):2402-2409.
PMID: 32828043
Objective: Sub-motor threshold 5 Hz repetitive paired associative stimulation (5 Hz-rPAS) produces a long-lasting increase in corticospinal excitability. Assuming a spike-timing dependent plasticity-like (STDP-like) mechanism, we hypothesized that 5 Hz-rPAS...
2.
De Felice F, Megiorni F, Pietrantoni I, Tini P, Lessiani G, Mastroiacovo D, et al.
Eur Rev Med Pharmacol Sci
. 2019 Apr;
23(6):2669-2680.
PMID: 30964194
Objective: Endothelial dysfunction (ED) predisposes to venous thrombosis (VT) and post-thrombotic syndrome (PTS), a long-term VT-related complication. Sulodexide (SDX) is a highly purified glycosaminoglycan with antithrombotic, pro-fibrinolytic and anti-inflammatory activity...
3.
Vomero M, Manganelli V, Barbati C, Colasanti T, Capozzi A, Finucci A, et al.
Arthritis Res Ther
. 2019 Jan;
21(1):39.
PMID: 30696478
Background: Autophagy has emerged as a key mechanism in the survival and function of T and B lymphocytes, and its activation was involved in apoptosis resistance in rheumatoid arthritis (RA)....
4.
Terranova C, Rizzo V, Morgante F, Maggio R, Calamuneri A, Chillemi G, et al.
Neural Plast
. 2018 Nov;
2018:4135708.
PMID: 30405710
Background: Surround inhibition is a system that sharpens sensation by creating an inhibitory zone around the central core of activation. In the motor system, this mechanism probably contributes to the...
5.
Rossi M, Taddei A, Fasciani I, Maggio R, Giorgi F
J Endocrinol Invest
. 2017 Jun;
41(1):67-73.
PMID: 28639207
Objective: Dichlorodiphenyltrichloroethane (DDT) is an organochlorine known for its pesticide properties and for its negative effects on human health. It was banned in most countries for its toxicity to the...
6.
Gori M, Barbaro B, Arciello M, Maggio R, Viscomi C, Longo A, et al.
J Cell Physiol
. 2015 Jul;
230(6):1400.
PMID: 26179116
No abstract available.
7.
Selvi E, Garcia-Gonzalez E, Maggio R, Lorenzini S, Santucci A, Galeazzi M
Clin Exp Rheumatol
. 2010 Jul;
28(4):591.
PMID: 20659416
No abstract available.
8.
Picchietti S, Belardinelli M, Taddei A, Fausto A, Pellegrino M, Maggio R, et al.
Cell Tissue Res
. 2009 Feb;
336(1):31-40.
PMID: 19214582
The thyroid-stimulating hormone (TSH) receptor (TSHr) was made specifically fluorescent by insertion of a tetracysteine motif (TSHr-FlAsH) into the C-terminal end and transiently transfected into COS-7 and HeLa cells. The...
9.
Selvi E, Lorenzini S, Garcia-Gonzalez E, Maggio R, Lazzerini P, Capecchi P, et al.
Clin Exp Rheumatol
. 2008 Sep;
26(4):574-81.
PMID: 18799087
Objective: To verify whether synthetic cannabinoids (CP55,940 and WIN55,212-2) are able to exert an anti-inflammatory effect on rheumatoid fibroblast-like synoviocytes (FLS) by down-regulating cytokine production, and determine whether this effect...
10.
Maggio R, Armogida M, Scarselli M, Salvadori F, Longoni B, Pardini C, et al.
Neurotox Res
. 2003 Jul;
1(4):285-97.
PMID: 12835096
Epidemiological studies have shown a reduced incidence of cancer in Parkinson's disease. Since nearly all parkinsonian patients with clinical impairment are treated with L-beta-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine (DA)ergic agonists, a...